Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Infect Genet Evol ; 54: 98-107, 2017 10.
Article in English | MEDLINE | ID: mdl-28645708

ABSTRACT

BACKGROUND: Migration and travel are major drivers of the spread of infectious diseases. Geographic proximity and a common language facilitate travel and migration in Mesoamerica, which in turn could affect the spread of HIV in the region. METHODS: 6092 HIV-1 subtype B partial pol sequences sampled from unique antiretroviral treatment-naïve individuals from Mexico (40.7%), Guatemala (24.4%), Honduras (19%), Panama (8.2%), Nicaragua (5.5%), Belize (1.4%), and El Salvador (0.7%) between 2011 and 2016 were included. Phylogenetic and genetic network analyses were performed to infer putative relationships between HIV sequences. The demographic and geographic associations with clustering were analyzed and viral migration patterns were inferred using the Slatkin-Maddison approach on 100 iterations of random subsets of equal number of sequences per location. RESULTS: A total of 1685/6088 (27.7%) of sequences linked with at least one other sequence, forming 603 putative transmission clusters (range: 2-89 individuals). Clustering individuals were significantly more likely to be younger (median age 29 vs 33years, p<0.01) and men-who-have-sex-with-men (40.4% vs 30.3%, p<0.01). Of the 603 clusters, 30 (5%) included sequences from multiple countries with commonly observed linkages between Mexican and Honduran sequences. Eight of the 603 clusters included >10 individuals, including two comprised exclusively of Guatemalans (52 and 89 individuals). Phylogenetic and migration analyses suggested that the Central and Southern regions of Mexico along with Belize were major sources of HIV throughout the region (p<0.01) with genetic flow southward from Mexico to the other nations of Mesoamerica. We also found evidence of significant viral migration within Mexico. CONCLUSION: International clusters were infrequent, suggesting moderate migration between HIV epidemics of the different Mesoamerican countries. Nevertheless, we observed important sources of transnational HIV spread in the region, including Southern and Central Mexico and Belize.


Subject(s)
HIV Infections , HIV-1/genetics , Adult , Central America/epidemiology , Female , HIV Infections/epidemiology , HIV Infections/transmission , HIV Infections/virology , Humans , Male , Mexico/epidemiology , Molecular Epidemiology , Young Adult
2.
PLoS One ; 11(10): e0164156, 2016.
Article in English | MEDLINE | ID: mdl-27736898

ABSTRACT

BACKGROUND: Increasing HIV pre-treatment drug resistance (PDR) levels have been observed in regions with increasing antiretroviral treatment (ART) coverage. However, data is lacking for several low/middle-income countries. We present the first PDR survey in Nicaragua since ART introduction in the country in 2003. METHODS: HIV-infected, ART-naïve Nicaraguan individuals were enrolled at Roberto Calderón Hospital, the largest national HIV referral center, from 2011 to 2015. HIV pol sequences were obtained at a WHO-accredited laboratory in Mexico by Sanger and next generation sequencing (NGS). PDR was assessed using the WHO surveillance drug resistance mutation (SDRM) list and the Stanford HIVdb tool. RESULTS: 283 individuals were enrolled in the study. The overall PDR prevalence based on the list of SDRMs was 13.4%. Using the Stanford HIVdb tool, overall PDR reached 19.4%; with both nucleoside and non-nucleoside reverse transcriptase inhibitor (NRTI and NNRTI) PDR levels independently reaching moderate levels (6.7% and 11.3% respectively). Protease inhibitor PDR was low (2.8%). Using NGS with 2% threshold to detect SDRMs, PDR increased to 25.3%. K103N and M41L were the most frequent SDRMs and were present mostly in proportions >20% in each individual. A significant temporal increase in NNRTI PDR was observed (p = 0.0422), with no apparent trends for other drug classes. Importantly, PDR to zidovudine + lamivudine + efavirenz and tenofovir + emtricitabine + efavirenz, the most widely used first-line regimens in Nicaragua, reached 14.6% and 10.4% respectively in 2015. Of note, a higher proportion of females was observed among individuals with PDR compared to individuals without PDR (OR 14.2; 95% CI: 7.1-28.4; p<0.0001). CONCLUSIONS: Overall PDR in the Nicaraguan cohort was high (19.4%), with a clear increasing temporal trend in NNRTI PDR. Current HIVDR to the most frequently used first-line ART regimens in Nicaragua reached levels >10%. These observations are worrisome and need to be evidenced to strengthen the national HIV program. Also, our observations warrant further nationally representative HIVDR surveillance studies and encourage other countries to perform national surveys. Cost-effectiveness studies are suggested to analyze the feasibility of implementation of baseline HIV genotyping as well as to review the choice of first-line ART regimens in Nicaragua.


Subject(s)
Anti-HIV Agents/pharmacology , Drug Resistance, Viral , HIV Infections/virology , HIV/genetics , pol Gene Products, Human Immunodeficiency Virus/genetics , Adult , Female , HIV/drug effects , High-Throughput Nucleotide Sequencing , Humans , Male , Mutation Rate , Nicaragua , Sequence Analysis, RNA
3.
Iatreia ; 1(1): 22-28, ago. 1988. tab
Article in Spanish | LILACS | ID: lil-82164

ABSTRACT

Con el fin de conocer su morbilidad respiratoria se estudiaron los 36 trabajadores de la Empres de Talcos de Yarumal (Antioquia-Colombia); a cada trabajador se le realizaron historia clinica y ocupacional; examen fisico; estudios radiologicos de torax; espirometria; pruebas de tuberculina e histoplasmina; baciloscopias y cultivos para micobacterias. Se hicieron igualmente mediciones del grado de contaminacion del ambiente laboral. Se encontro una alta frecuencia de sintomatologia respiratoria previa; la mitad de los trabajadores anomalias al examen fisico; dos terceras partes tenian anormalidades radiologicoas y una tercera parte anormalidades espirometricas


Subject(s)
Humans , Respiratory Tract Diseases/diagnosis , Respiratory Tract Diseases/physiopathology , Respiratory Tract Diseases/epidemiology , Talc/adverse effects , Smoking/complications , Occupational Diseases/etiology , Colombia
SELECTION OF CITATIONS
SEARCH DETAIL
...